Elekta
65.4 SEK -0.15%9 investors are following this company
Elekta provides medical technology. The company specializes in the development of clinical solutions for the treatment of cancer and brain diseases. Elekta's treatment system and planning software for radiation therapy and radiation surgery as well as other software systems are used in the healthcare industry to identify and analyze various health conditions. Operations are conducted on a global level, with headquarters in Stockholm.
Revenue
18.12B
EBIT %
11.25 %
P/E
19.18
Dividend yield-%
3.67 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
EKTA B
Daily low / high price
65.4 / 65.8
SEK
Market cap
25.09B SEK
Turnover
516.08K SEK
Volume
7.9K
Financial calendar
Interim report
2024-08-24
General meeting
2024-09-05
Half year dividend
2024-09-06
Interim report
2024-11-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Fjärde AP-fonden | 9.1 % | 6.7 % |
Laurent Leksell fam och bolag | 5.7 % | 30.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Elekta to become new issuer in the Swedish commercial paper market
Bokslutskommuniké, maj–april 2023/24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools